中枢性尿崩症的内分泌结局:神经影像「错配模式」的预测价值
研究纳入39例中枢性尿崩症患儿(29例特发性、10例朗格汉斯细胞组织细胞增生症),分析入院及随访期间332次脑磁共振的垂体柄厚度、对比增强模式与垂体大小。结果显示58.6%特发性患儿出现「错配模式」,该模式与垂体柄较大、垂体较小及生长激素缺乏相关。作者认为错配模式可能具有预后价值并可用于指导随访。
要点
- 29例特发性中枢性尿崩症患儿中17例(58.6%)出现垂体柄错配模式。
- 错配模式在出现后神经影像表现趋于稳定,LCH患者则在化疗后出现错配。
- 错配模式患者更常合并至少一种垂体激素缺陷,以生长激素缺乏更常见(P=0.033)。
核心结论
- 垂体柄错配模式见于中枢性尿崩症、垂体体积减小及垂体前叶功能异常的患者。
- 错配模式与特定基础疾病的关联需进一步研究。
- 由于错配模式患者垂体柄大小趋于稳定,作者推测该模式具有预后价值,可用于指导随访。
研究设计与样本
- 研究纳入39例中枢性尿崩症患儿,其中29例为特发性、10例为朗格汉斯细胞组织细胞增生症(LCH)。
- 分析入院时及随访期间的脑磁共振图像共332次,重点评估垂体柄厚度、对比增强模式及垂体腺大小,并分析T2-DRIVE与增强后T1加权图像。
主要发现
- 29例特发性中枢性尿崩症患者中17例(58.6%)呈现「错配模式」,即垂体柄厚度在T2-DRIVE与增强后T1加权图像之间存在差异。
- 错配模式出现后神经影像表现趋于稳定,而LCH患者在化疗后出现「错配」。
- 垂体柄较大的患者出现错配模式更频繁(P=0.003);这些患者近端与中部垂体柄尺寸随时间减小(P=0.045和P=0.006)。
- 错配模式患者的垂体腺更小(P<0.0001)。
- 错配模式患者更常出现至少一种垂体激素缺陷,以生长激素缺乏更常见(P=0.033)。
临床怎么用
- 作者认为错配模式可能具有预后价值,可用于指导随访。
- 原文未据此给出其他临床推荐。
局限性
- 错配模式与特定基础疾病的关联需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The etiology of central diabetes insipidus (CDI) in children is often unknown. Clinical and radiological features at disease onset do not allow discrimination between idiopathic forms and other conditions or to predict anterior pituitary dysfunction. OBJECTIVE: To evaluate the evolution of pituitary stalk (PS) thickening and the pattern of contrast-enhancement in relation with etiological diagnosis and pituitary function. METHODS: We enrolled 39 children with CDI, 29 idiopathic and 10 with Langerhans cell histiocytosis (LCH). Brain magnetic resonance images taken at admission and during follow-up (332 studies) were examined, focusing on PS thickness, contrast-enhancement pattern, and pituitary gland size; T2-DRIVE and postcontrast T1-weighted images were analyzed. RESULTS: Seventeen of 29 patients (58.6%) with idiopathic CDI displayed "mismatch pattern," consisting in a discrepancy between PS thickness in T2-DRIVE and postcontrast T1-weighted images; neuroimaging findings became stable after its appearance, while "mismatch" appeared in LCH patients after chemotherapy. Patients with larger PS displayed mismatch more frequently (P = 0.003); in these patients, reduction of proximal and middle PS size was documented over time (P = 0.045 and P = 0.006). The pituitary gland was smaller in patients with mismatch (P < 0.0001). Patients with mismatch presented more frequently with at least one pituitary hormone defect, more often growth hormone deficiency (P = 0.033). CONCLUSIONS: The PS mismatch pattern characterizes patients with CDI, reduced pituitary gland size, and anterior pituitary dysfunction. The association of mismatch pattern with specific underlying conditions needs further investigation. As patients with mismatch show stabilization of PS size, we assume a prognostic role of this peculiar pattern, which could be used to lead follow-up.
引用
- Bianco D, Napoli F, Morana G, et al. Endocrine Outcomes In Central Diabetes Insipidus: the Predictive Value of Neuroimaging "Mismatch Pattern". J Clin Endocrinol Metab. 2020. PMID: 32797230. doi:10.1210/clinem/dgaa540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。